Schedule 13G ownership disclosure

MARINUS PHARMACEUTICALS INC

Common Stock · CUSIP: 56854Q200

Event date: 2024-12-31

Filing-level shares
2,596,768
Percent of class
4.7%
  • The Vanguard Group

    Shares: 2,596,768 · Class: 4.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000316
Form type
SCHEDULE 13G/A
Filer
MARINUS PHARMACEUTICALS, INC.
CIK
CIK 1267813
Filed
Jan 31, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub